100 Clinical Results associated with Blue Ridge Pharmaceuticals, Inc.
0 Patents (Medical) associated with Blue Ridge Pharmaceuticals, Inc.
01 Jun 2002·Journal of Feline Medicine and SurgeryQ3 · AGRICULTURAL & FORESTRY SCIENCE
Inoculation with Bartonella Henselae Followed by Feline Herpesvirus 1 Fails to Activate Ocular Toxoplasmosis in Chronically Infected Cats
Q3 · AGRICULTURAL & FORESTRY SCIENCE
Article
Author: Kordick, DL ; Powell, CC ; Lappin, MR
Infection by Toxoplasma gondii is very common in cats although most remain disease free. The factors that trigger development of uveitis in some cats infected with T gondii have not been elucidated, but infection by more than one organism may be contributory. In this study, cats chronically infected with T gondii were inoculated with Bartonella henselae followed by FHV-1 to test the hypothesis that immune stimulation by multiple infections will reactivate ocular toxoplasmosis. Anterior uveitis and chorioretinitis were not detected in the cats with chronic T gondii infection thus allowing rejection of the hypothesis using this experimental design.
100 Deals associated with Blue Ridge Pharmaceuticals, Inc.
100 Translational Medicine associated with Blue Ridge Pharmaceuticals, Inc.